Document is current
Any future updates will be listed below
-
Authors
-
Funding
Funding for this research was provided by:
Foundation for the National Institutes of Health (5R01CA262710-02)
National Science Foundation (DMS 2113707)
National Science Foundation (DGE1745303)
Foundation for the National Institutes of Health (T32GM135117)
- License Information
-
More Information
Article History
Received: 30 June 2023
Accepted: 27 March 2025
First Online: 16 April 2025
Declarations
:
: Not applicable.
: Not applicable.
: While he does not consider any of these activities to be in conflict with the research in this committee, Giovanni Parmigiani wishes to disclose that he holds equity in Phaeno Biotechnologies and currently consults for Delphi Diagnostics.
